-
August 21, 2012
We recently downgraded Salix Pharmaceuticals, Ltd. (SLXP) to Neutral from Outperform. Salix faced a setback in ...
-
August 13, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted second quarter earnings of 79 cents per share, well above the Zacks ...
-
July 30, 2012
The market is currently down, with the Nasdaq decreasing 0.2%, the S&P 500 down 0.1% and the Dow slipping 0.1%. The ...
-
July 30, 2012
The market is having a bad day so far. The Nasdaq has fallen 0.2%; the S&P 500 has declined 0.1%; and the Dow is ...
-
July 11, 2012
Theravance Inc. (THRX) recently announced positive top-line results on TD-1211 from a phase IIb study, 0084. TD-1211 ...
-
July 06, 2012
CapLease Inc. (LSE), a real estate investment trust (REIT), recently entered into a revolving credit agreement with ...
-
June 29, 2012
Lexington Realty Trust (LXP), a real estate investment trust (REIT), recently announced that one of its subsidiaries ...
-
June 07, 2012
A joint venture subsidiary of Lexington Realty Trust (LXP), a real estate investment trust (REIT), recently ...
-
May 08, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted first quarter earnings of 67 cents per share, well above the Zacks ...
-
May 07, 2012
Salix Pharmaceuticals, Ltd. (SLXP) is facing a delay where the approval of two of its pipeline candidates is ...
-
March 21, 2012
Despite all of these uncertainties, investors still heavily focus on whether a company's new drug will be approved ...
-
January 18, 2012
Salix is a great candidate for growth investors.
-
July 26, 2011
While large-cap commercial real estate has continued its gains throughout 2011, smaller firms seem to be stuck in ...
-
June 16, 2011
Investors now have an opportunity to invest in the small-cap REIT sector with this new ETF.
-
March 31, 2011
Valeant offers a rare win-win bid for Cephalon.
-
March 03, 2011
Salix has taken another blow from the FDA, but seems too cheap given its prospects.
-
August 06, 2010
Thanks to low interest rates, investors are shying away from Government bonds and GICs.
